Biora Therapeutics, Inc. (BIOR)

NASDAQ: BIOR · IEX Real-Time Price · USD
0.840
-0.008 (-0.93%)
At close: May 23, 2022 4:00 PM
0.820
-0.020 (-2.334%)
After-hours:May 23, 2022 7:59 PM EDT
Market Cap154.65M
Revenue (ttm)1.19M
Net Income (ttm)-228.96M
Shares Out184.20M
EPS (ttm)-2.57
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,229,550
Open0.813
Previous Close0.848
Day's Range0.800 - 0.875
52-Week Range0.630 - 6.200
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateMay 10, 2022

About BIOR

Progenity, Inc., a biotechnology company, provides develops and commercializes molecular testing products in the United States. The company develops targeted oral delivery of biotherapeutics, including PGN-600, an orally delivered liquid formulation of tofacitinib for the treatment of ulcerative colitis; and PGN-001, an orally delivered variant of adalimumab for the treatment of ulcerative colitis. It also develops systemic oral delivery of biotherapeutics, which include PGN-OB, a combination product of a variant of adalimumab and the Oral Biot...

IndustryHealth Care Providers & Services
IPO DateJun 19, 2020
CEOHarry Stylli
Employees124
Stock ExchangeNASDAQ
Ticker SymbolBIOR
Full Company Profile

Financial Performance

In 2021, BIOR's revenue was $1.25 million, an increase of 669.75% compared to the previous year's $162,000. Losses were -$247.41 million, 28.5% more than in 2020.

Financial Statements

News

Biora Therapeutics Announces New Patents for Targeted Therapeutics Platform

Marks 29 Patents Worldwide Directed to Biora's Device Localization Technology Marks 29 Patents Worldwide Directed to Biora's Device Localization Technology

4 days ago - GlobeNewsWire

Biora Therapeutics to Participate in Upcoming H.C. Wainwright Global Investment Conference

SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today announced that the Company's management team will be pres...

1 week ago - GlobeNewsWire

Biora Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results

Completed transformation with the launch of Biora Therapeutics to reflect the company's focus on oral therapeutic solutions

1 week ago - GlobeNewsWire

BIOR Stock Starts Trading as Progenity's Rebrand Takes Shape. What to Know.

Biora's product is supposed to enable biologics to be delivered directly to GI tracts. BIOR stock is a favorite of retail investors.

1 week ago - InvestorPlace

Progenity Announces Successful Transfer of Liquid Biopsy Technologies

Enumera Molecular Formed to Develop and Commercialize Next-Generation Solutions for Liquid Biopsy Enumera Molecular Formed to Develop and Commercialize Next-Generation Solutions for Liquid Biopsy

2 weeks ago - GlobeNewsWire

Progenity to Report First Quarter Financial Results and Provide Corporate Update as Biora Therapeutics, Inc.

SAN DIEGO, May 03, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG) today announced that it will report first quarter ended March 31, 2022 financial results on Tuesday, May 10, 2022 after the clo...

2 weeks ago - GlobeNewsWire

Progenity Appoints Paul Shabram to Lead Technical Operations of the Company's Ingestible Drug/Device Platforms

Expanding Leadership Team to Accelerate Development of Innovative Therapeutic Delivery Platforms Expanding Leadership Team to Accelerate Development of Innovative Therapeutic Delivery Platforms

4 weeks ago - GlobeNewsWire

Progenity to Become Biora Therapeutics as it Completes Transformation

Upcoming Change Reflects the Company's Focus on Oral Delivery of Biotherapeutics Upcoming Change Reflects the Company's Focus on Oral Delivery of Biotherapeutics

1 month ago - GlobeNewsWire

Progenity Announces Two Poster Presentations at Controlled Release Society 2022

SAN DIEGO, April 06, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announ...

1 month ago - GlobeNewsWire

Progenity Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results

Accelerated Company Transformation Toward Oral Delivery of Biotherapeutics and Targeted Therapeutics Programs

1 month ago - GlobeNewsWire

Should You Invest in These Penny Stocks Next Month? 3 to Watch

Will these penny stocks be on your watchlist in April? The post Should You Invest in These Penny Stocks Next Month?

Other symbols:CENNDIDI
2 months ago - PennyStocks

Penny Stocks To Buy Now? 4 Short Squeeze Stocks To Watch This Week

Short squeeze stocks to watch this week. The post Penny Stocks To Buy Now?

Other symbols:EVLOSEACXELA
2 months ago - PennyStocks

Progenity to Report Fourth Quarter and Full-Year 2021 Financial Results and Provide Corporate Update

SAN DIEGO, March 16, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announ...

2 months ago - GlobeNewsWire

Progenity Progresses its Drug Delivery System Clinical Device Performance Studies

Clinical Device Performance Study in Healthy Volunteers Demonstrated Accurate Localization and Delivery

2 months ago - GlobeNewsWire

Progenity Announces Acceptance of Three Abstracts at Digestive Disease Week 2022

SAN DIEGO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announc...

2 months ago - GlobeNewsWire

Progenity Shares Two Poster Presentations on Treatment of Gastrointestinal Disorders at ECCO'22

Patient data establishes key correlations for therapeutic exposure in tissue and alternative inflammatory pathways, supporting the hypotheses of targeted therapeutic delivery and potential combination t...

3 months ago - GlobeNewsWire

Progenity Shares Oral Presentation on Treatment of Gastrointestinal Disorders at 34th Belgian Week of Gastroenterology

Dr. Bram Verstockt presented key patient data establishing correlation between drug levels in colon and clinical outcomes Dr. Bram Verstockt presented key patient data establishing correlation between d...

3 months ago - GlobeNewsWire

Top Penny Stocks to Buy Right Now? 3 to Watch in Mid-February

Here's three penny stocks that investors are watching rig The post Top Penny Stocks to Buy Right Now? 3 to Watch in Mid-February   appeared first on Penny Stocks to Buy, Picks, News and Information | Pe...

Other symbols:DIDITCBP
3 months ago - PennyStocks

Top Reddit Penny Stocks That Investors Are Watching Right Now

Reddit penny stocks are heating up, here's three to know about The post Top Reddit Penny Stocks That Investors Are Watching Right Now appeared first on Penny Stocks to Buy, Picks, News and Information |...

Other symbols:EBONPHUN
3 months ago - PennyStocks

3 Penny Stocks Climbing During Today's Trading Session

These penny stocks climbed today, here's what you need to know The post 3 Penny Stocks Climbing During Today's Trading Session  appeared first on Penny Stocks to Buy, Picks, News and Information | Penny...

Other symbols:BBIGKAVL
3 months ago - PennyStocks

These 4 Penny Stocks Exploded Today, Here's Why

These penny stocks climbed today, here's what you need to know The post These 4 Penny Stocks Exploded Today, Here's Why appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols:DIDISOPAVLDR
3 months ago - PennyStocks

Here's 3 Trending Penny Stocks to Add to Your Watchlist in February

Check these trending penny stocks out for your watchlist The post Here's 3 Trending Penny Stocks to Add to Your Watchlist in February appeared first on Penny Stocks to Buy, Picks, News and Information |...

Other symbols:BBIGMETX
3 months ago - PennyStocks

Progenity Strengthens Intellectual Property for Single-Molecule Detection Technology with Additional Patent

SAN DIEGO, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced the award of another new patent related to its single-molecule detection...

3 months ago - GlobeNewsWire

5 Top Penny Stocks To Buy Now According To Reddit

5 Reddit penny stocks to watch right now. The post 5 Top Penny Stocks To Buy Now According To Reddit appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols:KOSRELIRIGSDC
3 months ago - PennyStocks

Can These Penny Stocks Climb This Week? 4 To Watch Right Now

Are these penny stocks on your watchlist for next week? The post Can These Penny Stocks Climb This Week?

Other symbols:ARDSBXRXWIMI
4 months ago - PennyStocks